Dewire Jane, Calkins Hugh
Department of Medicine, Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
J Atr Fibrillation. 2013 Feb 12;5(5):739. doi: 10.4022/jafib.739. eCollection 2013 Feb-Mar.
Catheter ablation of atrial fibrillation (AF) is an important treatment modality for patients with AF. Although the superiority of catheter ablation of AF over antiarrhythmic drug therapy has been demonstrated in middle aged patients with paroxysmal AF, the role of catheter ablation in other patient subgroups, particularly in the elderly, those with heart failure, and those with long standing persistent AF has not been as well defined. Furthermore, although AF ablation can be performed with reasonable efficacy and safety in experienced hands, late recurrences of AF a year or more following AF ablation are not uncommon. Fortunately the techniques and tools used for AF ablation continue to evolve and it is likely that the outcomes of AF ablation will improve further in the future.
导管消融治疗心房颤动(房颤)是房颤患者的一种重要治疗方式。尽管在中年阵发性房颤患者中已证实导管消融治疗房颤优于抗心律失常药物治疗,但导管消融在其他患者亚组中的作用,特别是在老年人、心力衰竭患者和长期持续性房颤患者中,尚未得到明确界定。此外,尽管在经验丰富的医生操作下,房颤消融可以取得合理的疗效和安全性,但房颤消融术后一年或更长时间的晚期复发并不少见。幸运的是,用于房颤消融的技术和工具不断发展,未来房颤消融的效果可能会进一步改善。